Found 13,575 investors
SuperSeed Ventures
London, England, United Kingdom
SuperSeed invests in seed stage B2B SaaS/AI companies and help them reach their first £1m in revenue
Artificial Intelligence
B2B
SaaS
Venture Capital
Supply Chain Equity Partners
United States
Founded in 2007, Supply Chain Equity Partners is a private equity firm based in Tampa, Florida. The firm focuses exclusively on the distribution industry. The firms seek to invest in the B2B distributor and related logistics companies that are in the supply chain, regardless of sub-sector.
Private Equity Firm
Supply Chain Labs
Gurgaon, Haryana, India
Supply Chain Labs is a 6-month structured program for early and growth-stage startups in the supply chain domain.
Finance
Financial Services
Supply Chain Management
Accelerator
Supply Chain Ventures
Boston, Massachusetts, United States
Supply Chain Ventures is an angel and early-stage venture capital partnership.
SaaS
Supply Chain Management
Venture Capital
Venture Capital
SupplyOn
Hallbergmoos, Bayern, Germany
SupplyOn connects you with your business partners worldwide and ensures the long-term success of your supply chain.
Industrial Manufacturing
Information Technology
Internet of Things
Medical Device
Railroad
Supply Chain Management
Accelerator
Venture Capital
Surdna Foundation
New York, New York, United States
The Surdna Foundation seeks to foster just and sustainable communities in the United StatesвАЭ communities guided by principles of social.
Venture Capital
Surender Punia
United Kingdom
Mr. Crispin Comonte serves as Managing Partner at Ironbridge Capital Partners. He has over 20 years experience working in corporate finance, advising on M&A and investment deals. Before joining Ironbridge, Crispin worked in the strategy and corporate finance department of BBC Worldwide and most recently as the corporate finance director of Microsoft founder Paul Allen's Vulcan European Media fund where he helped lead investments in The Hospital Group (Covent Garden based private members club, TV and film production, TV studios, and restaurants) and European TV sports network NASN. Originally trained as a barrister, he began his corporate finance career in the investment banking division of Robert Fleming & Co. advising on M&A deals. Alongside other Ironbridge Partners Crispin is an active venture and property investor. Private company portfolio investments include Shopwave, Marktomarket, RL Automotive, Orange Eyes (owners of the Gruffalo childrens brand) and ICS.
Individual/Angel
Suresh Jain
United Kingdom
Mr. Nuno Miller serves as Chief Operating Officer at N Brown Group. He was Head of Digital Channels at SONAE. He was a Chief Technology Officer & Managing Director at Videdressing. He served as Chief Information Officer at Farfetch. He brings to farfetch.com a broad experience base in defining and implementing IT strategy, along with an extensive knowledge of the worldwide apparel and textile business. He has worked at Deloitte and Parfois previous to joining farfetch.
Individual/Angel
Suresh Shankar
United States
Mr. Michael Potts serves as Retired CEO Consultant at Webroot. He is also an Angel Investor. He also served as President, Chief Executive Officer and Board Member at Lancope. He served as Board Member at Terma Software Labs and Evident. He leads all aspects of Lancope's strategic direction and day-to-day operations. Prior to Lancope he served as President and CEO of AirDefense, where he led the company's breakthrough wireless security growth of more than 300% in tow and a half years and completed the strategic all cash acquisition of the company by Motorola (NYSE:MOT) in September 2008. Previously, he served as CEO of Clickfox, an analytic solutions' provider, and as a merger & acquisition advisor to a number of venture backed companies. In 1998, he was appointed President of Jacada (NASDAQ: JCDA), a software integration company. He leads the acquisition strategy of more than 1,000 customers during his 7-year tenure and was a key contributor to Jacada's initial public offering raising more than $55m on an initial $200m valuation in 1999. Later that year the valuation of the company subsequently surpassed $650m. While serving as President, Computerworld named Jacada one of the top 10 places to work in the Southeast. Prior to Jacada, he spent 7 years in various sales and marketing roles at MSA, a financial application software company, subsequently acquired by Dun and Bradstreet (NYSE: DNB). He has served on the board of directors of the American Israel Chamber of Commerce, the American Electronics Association (AEA) and currently serves as an advisor and/or board member to several emerging technology companies. He completed his BBA in Marketing in 1984 at the University of Georgia.
Individual/Angel
Sure Ventures
London, England, United Kingdom
Sure Ventures offer investors a listed vehicle that aims to achieve a diversified exposure to early stage technology companies.
Venture Capital
Surge Impact Foundation
United States
Mr. Pervinder Johar serves as Chief Executive Officer at REZ-1. He also serves as Board Member at Syncreon Group. He served as Board Member at LiveSource. He is responsible for the day-to-day leadership of the company and joins REZ-1 from Edgeverve where he served as CEO of the InfoSys subsidiary. Prior to that, Mr. Johar was President and CEO at Steelwedge Software Inc., a market leader in supply planning and sales & operations planning. Under his leadership, Steelwedge successfully orchestrated a merger with E2open to form the largest purely cloud-based supply chain software company in the world. Mr. Johar previously served as Vice President of Global Supply Chain Systems at HP. In this role, he was responsible for strategy and execution of worldwide supply chain management, manufacturing, product life cycle management, order-to-cash, and procure-to-pay business processes and IT systems for HP's supply chain, one of the largest in the world. Mr. Johar previously held the position of CTO at Manhattan Associates, a leading provider of supply chain execution solutions, where he was responsible for global research, development, and quality assurance. He received a Master of Science in Computer Science from Villanova University, and an MBA from Boston University.
Individual/Angel
Surgical Frontiers
Logan, Utah, United States
Surgical Frontiers is making life better for the injured and impaired by funding.
Biotechnology
Health Care
Medical Device
Venture Capital
Sur La Maison
United Kingdom
Founded in 2021, Sur La Maison is a growth capital firm based in London, United Kingdom. The firm specializes in providing growth capital to businesses in consumer goods, technology and software as a service sectors.
Growth Capital
Surlamer Investments
United States
Surlamer Investments is an investment firm and is based in Newport Beach, California. The firm invests in private companies, real estate and publicly traded securities. It invests in companies operating in the education, media, medical technology and wearable devices sectors. It also invests in commercial and residential real estate, including office properties, retail centers, single-family homes, condos and commercial lands. It also manages a hedge fund that employs a long-short equity strategy focused on macro investment themes.
Venture Capital
Surround Ventures
New York, New York, United States
Surround Ventures invests in Israeli-driven technology startups disrupting media, entertainment, sports, and e-commerce.
Venture Capital
Suryakanth Mainak
Kolkata, West Bengal, India
S. B. Mainak (59),joined the ITC Board as a Non-Executive Director effective April 25, 2014, representing LIC. A qualified Chartered Acco...
Susan Athey
United States
Dr. Ian Garner co-founded and served as Chief Scientific Officer and Board Member at ProFactor Pharma. Ian graduated with a BSc Hons in Genetics from Leeds University followed by a PhD in Molecular Biology at the University of Edinburgh. From 1977-79 he worked on the first use of genetic engineering in an industrial process whilst at ICI. The postdoctoral experience was gained at the Pasteur Institute in Paris following which, he returned to the UK to work in the UK Biotechnology sector. Ian worked with Delta Biotechnology (Nottingham) 1988-90, is responsible for the expression of rFVIII in the milk of transgenic livestock and mammalian cells in vitro. In 1990; he joined PPL Therapeutics as Assistant Director of Research, where he further developed this technology in Scotland and the USA. During his 9 years with the company, Ian performed a range of functions including Research Management and Product Discovery and had significant exposure to Business Development and Intellectual Property Management. Ian has overseen the production of over 30 recombinant proteins including five protein members of the blood coagulation cascade. Ian joined Stem Cell Sciences UK as Chief Operating Officer in 2000, establishing the company's UK base in Edinburgh. In 2003, Ian was appointed CEO at NCIMB Ltd, Aberdeen, and led them to the verge of a public listing. Since 2005, Ian has been operating as an independent consultant to the Life Sciences Sector in the UK and Europe.
Individual/Angel
Susan Fox
Sweden
Mr. Anders Ferntoft serves as Executive at East Sweden Tillväxtkapital. Mr. Pernes also serves as Chairman of the Board at Linkura.
Individual/Angel
Susan Hanemann Rogol
United States
Dr. Kenneth Melani serves as Managing Partner at Velocity Fund Partners. Dr. Melani also is an Angel Investor. He serves as Board Member at Telcare. Dr. Melani served as Chairman at InClinica. He is a seasoned executive with over thirty years of experience across the health care industry. As President and owner of KRM Group, LLC, Dr. Melani provides consultative services to health care service companies, pharmaceutical manufacturers and private equity firms. Prior to starting KRM Group, Dr. Melani was President and CEO of Highmark Inc., where under his direction; Highmark grew to be the seventh-largest insurance company in the United States with over 32 million covered lives and over $15 Billion in revenue. Dr. Melani's contribution as a board member with organizations such as Telcare, Xodus Medical, Melanovus, Carmolex, MedExpress and others has provided invaluable visionary guidance fueled by his vast experience and success in the healthcare industry. Dr. Melani has an undergraduate degree in Chemistry from Washington & Jefferson College and a medical degree from Wake Forest University's Bowman Gray School of Medicine. He serves as a Member of the Advisory Board at 37celcius.
Individual/Angel
Susan Levine
Boston, Massachusetts
Managing Director at Bain Capital
Consumer Internet
E-commerce
FinTech
Showing 12141 to
12160 of
13,575 results